Diagnostic characteristics of supplemental laboratory criteria for incomplete Kawasaki disease in children with complete Kawasaki disease
Hyun Ok Jun (Jun HO), Jeong Jin Yu (Yu JJ), So Yeon Kang (Kang SY), Chang Deok Seo (Seo CD), Jae Suk Baek (Baek JS), Young-Hwue Kim (Kim YH), Jae-Kon Ko (Ko JK)
Clin Exp Pediatr. 2015;58(10):369-373.   Published online 2015 Oct 21     DOI: https://doi.org/10.3345/kjp.2015.58.10.369
Citations to this article as recorded by Crossref logo
Antibodies and Immunity During Kawasaki Disease
Mark Daniel Hicar
Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef
Kawasaki-like disease in children with COVID-19
Ummusen Kaya Akca, Selman Kesici, Yasemin Ozsurekci, Hayrettin Hakan Aykan, Ezgi Deniz Batu, Erdal Atalay, Selcan Demir, Erdal Sag, Dogus Vuralli, Benan Bayrakci, Yelda Bilginer, Seza Ozen
Rheumatology International.2020; 40(12): 2105.     CrossRef
N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease
Moises Rodriguez-Gonzalez, Alvaro A Perez-Reviriego, Ana Castellano-Martinez, Helena M Cascales-Poyatos
Biomarkers in Medicine.2019; 13(4): 307.     CrossRef
B Cells and Antibodies in Kawasaki Disease
Michael E. Lindquist, Mark D. Hicar
International Journal of Molecular Sciences.2019; 20(8): 1834.     CrossRef
Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment
Yu-Mi Seo, Hyun-Mi Kang, Sung-Churl Lee, Jae-Won Yu, Hong-Ryang Kil, Jung-Woo Rhim, Ji-Whan Han, Kyung-Yil Lee
Korean Journal of Pediatrics.2018; 61(5): 160.     CrossRef
Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease
Meghan Martin, Brian H. Wrotniak, Mark Hicar, Ravi Jhaveri
PLOS ONE.2018; 13(3): e0193539.     CrossRef
Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
Hong-Ryang Kil, Jae-Won Yu, Sung-Churl Lee, Jung-Woo Rhim, Kyung-Yil Lee
Pediatric Rheumatology.2017;[Epub]     CrossRef